Viral Clearance

Viral Clearance
Product Description

Viral Clearance studies are a critical preventative measure to ensure the security of biological products. Accidental viral contaminations can unfortunately happen during the manufacturing process. The process must comprise manufacturing steps which reduce contamination of the final products to an acceptable level for the safety of the patient. They are required for a multitude of biotherapeutics products that include medical devices, monoclonal antibodies, gene therapy products, blood, and plasma products from donors.

Read more Show less

Texcell

  • Country/Region:
    France
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Contract Manufacturer
View company profile

Texcell

  • Country/Region:
    France
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Contract Manufacturer
View company profile

More Products from Texcell (2)

  • Cell Banking

    Product Cell Banking

    Guidances on pharmaceutical development insist on the necessity to consistently deliver the intended performance of the products. Using living cells as part of the manufacturing process is a challenge. Homogeneous, large cell banks are the keys to meet these exacting requirements.
  • in vivo & in vitro Bioassay

    Product in vivo & in vitro Bioassay

    - Cell based assays/potency assays during development - Immunogenicity, TK/PK, ADA and neutralizing Antibody Testing - Immunotoxicology studies - Sample pre analytics: serum/plasma isolation, PBMC isolation & storage - Biobanking - Read-outs: ELISA, ECLIA, Flow cytometry, ELISpot, HAI, proliferation...